Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy. | Cancer Immunol Res | 2025 | 40742385 | PubTator, text mining | PubMed |
| Development of a Novel, Pulmonary Endovascular Device to Treat Patients With Pulmonary Hypertension. | Pulm Circ | 2025 | 40741160 | PubTator, text mining | PubMed |
| Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs. | Sci Rep | 2025 | 40739397 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
| Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer. | Front Immunol | 2025 | 40735323 | PubTator, text mining | PubMed |
| Reassessment of the Current Iron Deficiency Definition in Pulmonary Hypertension. | Pulm Circ | 2025 | 40734683 | PubTator, text mining | PubMed |
| The value of acetylation reader YEATS2 in hepatocellular carcinoma management. | Sci Rep | 2025 | 40731114 | PubTator, text mining | PubMed |
| Impact of epiretinal membrane peeling on steroid dependency in uveitic eyes: a retrospective analysis. | Int J Retina Vitreous | 2025 | 40731032 | PubTator, text mining | PubMed |
| Molecular Interactions Between NK Cells and Acute Leukemic Cells: KIR2DL5 Drastically Limits NK Cell Responses. | J Clin Immunol | 2025 | 40728766 | PubTator, text mining | PubMed |
| The Immune Regulatory Functions of CD226 and Its Implications in Immune-Mediated Diseases. | Biomolecules | 2025 | 40723878 | PubTator, text mining | PubMed |
| Abstracts of the 3rd UNICA Sport Science International Conference 2024. | Sports Med Open | 2025 | 40719936 | PubTator, text mining | PubMed |
| Proximity Extension Assay identifies new targets of grey matter pathology in multiple sclerosis. | Mult Scler Relat Disord | 2025 | 40714728 | PubTator, text mining | PubMed |
| Expression and clinical significance of CD155, FGL1, Galectin-9, and PD‑L1 in breast cancer with neoadjuvant chemotherapy. | Med Oncol | 2025 | 40711645 | PubTator, text mining | PubMed |
| Dual targeting of CD155/TIGIT and PD-L1/PD-1 immune checkpoints potentiates NK cell-mediated cytotoxicity in medulloblastoma. | Neurooncol Adv | 2025 | 40703802 | PubTator, text mining | PubMed |
| Identification of a disulfidptosis-correlated ferroptosis prognostic model in breast cancer. | Medicine (Baltimore) | 2025 | 40696618 | PubTator, text mining | PubMed |
| Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL. | Cell | 2025 | 40669460 | PubTator, text mining | PubMed |
| Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejection. | J Clin Invest | 2025 | 40663403 | PubTator, text mining | PubMed |
| Integrative Multi-Omics Analysis and Experimental Validation Identify SPOP as a Prognostic Biomarker and Immune Regulator in Lung Adenocarcinoma. | J Cancer | 2025 | 40657370 | PubTator, text mining | PubMed |
| Targeting CD155 in lung adenocarcinoma: A5 nanobody-based therapeutics for precision treatment and enhanced drug delivery. | Signal Transduct Target Ther | 2025 | 40634277 | PubTator, text mining | PubMed |
| Immune profiling of pediatric germ cell tumors identifies key cell populations and novel therapeutic targets. | Front Immunol | 2025 | 40621458 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=14